Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients

Regulation of Membrane-Type 4 Matrix Metalloproteinase by SLUG Contributes to Hypoxia-Mediated Metastasis

(2015) Chi-Hung Huang et al.   NEOPLASIA

Y-Box Binding Protein-1 Induces the Expression ofCD44andCD49fLeading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance

(2010) Karen To et al.   CANCER RESEARCH

Stat3 Orchestrates Tumor Development and Progression: The Achilles Heel of Head and Neck Cancers?

(2010) M. Masuda et al.   CURRENT CANCER DRUG TARGETS

YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma

(2010) Regina Holzmüller et al.   INTERNATIONAL JOURNAL OF CANCER

Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer

(2010) Masaki Kashihara et al.   Journal of Thoracic Oncology

The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells

(2010) J Dhillon et al.   ONCOGENE

Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition

(2009) Valentina Evdokimova et al.   CANCER CELL

Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth

(2009) M. Shiota et al.   CANCER RESEARCH

Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients

(2009) Fangwei Xie et al.   CLINICAL & EXPERIMENTAL METASTASIS

Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells

(2009) Q.-Q. Li et al.   CLINICAL CANCER RESEARCH

Nuclear expression of YB-1 in diffuse large B-cell lymphoma: correlation with disease activity and patient outcome

(2009) WenLing Xu et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis

(2009) Neelam G. Shah et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy

(2009) Oleg Gluz et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer

(2009) William H. Allum et al.   JOURNAL OF CLINICAL ONCOLOGY

The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1

(2009) A Astanehe et al.   ONCOGENE

Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells

(2009) M R Finkbeiner et al.   ONCOGENE

STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells

(2009) Maureen M. Sherry et al.   STEM CELLS

Consensus Statement on the Classification and Terminology of Neck Dissection

(2008) K. Thomas Robbins et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice

(2008) Cathy Lee et al.   CANCER RESEARCH

Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition

(2008) Alexandre Bozec et al.   EUROPEAN JOURNAL OF CANCER

TNM-based stage groupings in head and neck cancer: Application in cancer of the hypopharynx

(2008) Stephen F. Hall et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

(2008) Joel Tepper et al.   JOURNAL OF CLINICAL ONCOLOGY

Current status of biomarkers in head and neck cancer

(2008) Steven S. Chang et al.   JOURNAL OF SURGICAL ONCOLOGY

Y-Box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer

(2008) Wei-Lin Tay et al.   MODERN PATHOLOGY

Recent Advances in Head and Neck Cancer

(2008) Robert I. Haddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recurrence interval affects survival after local relapse of oral cancer

(2008) Thomas Mücke et al.   ORAL ONCOLOGY

Survival following primary surgery for oral cancer

(2008) Simon N Rogers et al.   ORAL ONCOLOGY

Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma

(2008) Paras Jethwa et al.   WORLD JOURNAL OF GASTROENTEROLOGY